Channels Correction to “Effectiveness of Influenza Vaccines in Italy in the 2024/2025 Season: A Nationwide, Test‐Negative Design Study Based on Surveillance Records”
Correction to “Burden of Severe Disease Associated With Influenza, SARS‐CoV‐2 and RSV in Spain During the 2024‐2025 Winter Season.”
Host Species Contribution to the Spatiotemporal Dynamics of the 2024–2025 H5N1 Epidemic in Italy
Applying the Moving Epidemic Method to Emergency Department Syndromic Surveillance to identify the Start of Influenza Seasons in New South Wales, Australia
Surveillance of Migratory Shorebirds and Seabirds in 2024 in Australia Reveals Incursions of a Diversity of Low Pathogenicity Avian Influenza Viruses, but Not High Pathogenicity Avian Influenza H5N1
Serological Surveillance of Avian Influenza Virus Exposure Using Paired Sera Among Occupational Contacts in Taiwan, January–September 2025
Influenza Antiviral Prescriptions in the US Inpatient and Outpatient Settings During the 2015–2022 Influenza Seasons
Reduction in Respiratory Syncytial Virus (RSV)‐Related Outpatient and Inpatient Cases Among Infants During the Initial 2024/2025 Season Following Nirsevimab Recommendation in Germany
Correlations and Timeliness of Respiratory Syncytial Virus Surveillance Indicators—United States, 2018–2024
Immunogenicity of a Multi‐Epitope Influenza Composite Peptide Vaccine Targeting Human, Swine, and Avian Viruses: Advancing Pandemic Preparedness
Evaluating Analytic Approaches to Determining Respiratory Syncytial Virus Seasonality—United States, 2014–2024
Genomic Surveillance of SARS‐CoV‐2 in Senegal (2020–2024): Variant Turnover, Omicron Introductions, and Interregional Spread
A Sequence‐Based Update on Amino Acid Substitutions in Influenza Polymerase Acidic Protein in Europe That Alter Baloxavir Susceptibility From 2009 to 2025
Gender Divergence in COPD Phenotypes and Narrowing Urban–Rural Diagnostic Gaps: A Surveillance Study in Chongqing, China, 2020–2024
Secondary organizing pneumonia complicating influenza B
Epidemiology, Genomic Diversity, and Evolutionary Dynamics of Human Metapneumovirus Over 7 Years of Integrated Community‐ and Hospital‐Based Sentinel Surveillance in Senegal, 2018–2024
Hypertransaminasemia Is a Marker of Severity in Children Hospitalized for Influenza
Antiviral Resistance in Influenza: Clinical and Public Health Implications
Migratory Bird and Marine Mammal Surveillance Fails to Find Evidence for an HPAI H5N1 2.3.4.4b Incursion Into Australia in 2025
Ecology of Low Pathogenicity Avian Influenza Virus H7 in Wild Birds in South‐Eastern Australia Prior to Emergence of High Pathogenicity Avian Influenza H7 in Poultry
Sociodemographic Determinants of Hospitalized Exacerbations in Exposure-Defined COPD Phenotypes: A Nationwide Prospective Cohort Study in China
Association Between Chronic Obstructive Pulmonary Disease and Survival in Patients with Lung Cancer: A Nationwide Cohort Study
Characteristics and Risk Factors Associated With Hospitalization and Severe Disease in Patients Aged ≥ 60 Years With Human Metapneumovirus Infection Over Three Consecutive Seasons (2021–2024) in Valladolid, Spain. The VALLAVIRUS Study
Hemagglutination Inhibition and Alternate Serologic Responses Following Influenza A(H3N2) Virus Infection
Dipeptidyl Peptidase-4 Inhibitor Use and Risk of Major Adverse Cardiovascular Events in Patients with COPD and Diabetes: A Nationwide Retrospective Cohort Study
